Mechanism of Oncogenic Signal Activation by the Novel Fusion Kinase FGFR3–BAIAP2L1Yoshito Nakanishi, Masahiro Aoki(Aichi Cancer Center)Molecular Cancer TherapeuticsJanuary 14, 201510.1158/1535-7163.mct-14-0927-tCited by 60SaveCiteExport RISWatch citationsRelated PapersAntitumor activity of <scp>the MEK</scp> inhibitor trametinib on intestinal polyp formation in <i>Apc</i><sup>Δ716</sup> mice involves stromal <scp>COX</scp>‐2|Cancer Science|2015|9